{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:03:27Z","timestamp":1791389007997,"version":"4.3.3"},"reference-count":48,"publisher":"Informa UK Limited","issue":"17","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2015,9,30]]},"DOI":"10.2217\/fon.15.114","type":"journal-article","created":{"date-parts":[[2015,8,14]],"date-time":"2015-08-14T14:19:13Z","timestamp":1439561953000},"page":"2459-2470","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":62,"title":["L-Asparaginase and Venous Thromboembolism in Acute Lymphocytic Leukemia"],"prefix":"10.1080","volume":"11","author":[{"given":"Gaurav","family":"Goyal","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Creighton University School of Medicine, 2500 California Plaza, Omaha, NE68178, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijaya Raj","family":"Bhatt","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Hematology-Oncology, University of Nebraska Medical Center, 987680 Nebraska Medical Center, Omaha, NE68198, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,8,14]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.06.007"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2008.08.004"},{"issue":"9","key":"e_1_3_2_5_1","first-page":"600","article-title":"Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia","volume":"7","author":"Earl M","year":"2009","unstructured":"Earl M . Incidence and management of asparaginase-associated adverse events in patients with acute lymphoblastic leukemia. Clin. Adv. Hematol. Oncol.7(9), 600\u2013606 (2009).","journal-title":"Clin. Adv. Hematol. Oncol."},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.leu.2400834"},{"issue":"2","key":"e_1_3_2_7_1","first-page":"107","article-title":"Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961)","volume":"18","author":"Grigoryan RS","year":"2004","unstructured":"Grigoryan RS , PanosyanEH, SeibelNL, GaynonPS, AvramisIA, AvramisVI. Changes of amino acid serum levels in pediatric patients with higher-risk acute lymphoblastic leukemia (CCG-1961). In Vivo18(2), 107\u2013112 (2004).","journal-title":"In Vivo"},{"issue":"5","key":"e_1_3_2_8_1","first-page":"587","article-title":"Critical roles of glutamine as nitrogen donors in purine and pyrimidine nucleotide synthesis: asparaginase treatment in childhood acute lymphoblastic leukemia","volume":"20","author":"Cory JG","year":"2006","unstructured":"Cory JG , CoryAH. Critical roles of glutamine as nitrogen donors in purine and pyrimidine nucleotide synthesis: asparaginase treatment in childhood acute lymphoblastic leukemia. In Vivo20(5), 587\u2013589 (2006).","journal-title":"In Vivo"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4615-4811-9_69"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0034-1370795"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2012.290"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2007.06677.x"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08524.x"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-04-015511"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH12-11-0845"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.12948"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF02592556"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0145-2126(00)00017-5"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2006.051238"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.3.547"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1987.5.5.811"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.21665"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-07-231084"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0b013e31828dc614"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1097\/MPH.0000000000000333"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-027714"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.8.2734"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V99.6.1986"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/mpo.2950230404"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2011.08588.x"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60592-9"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1986.tb04121.x"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-200107000-00005"},{"issue":"2","key":"e_1_3_2_34_1","first-page":"235","article-title":"Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study","volume":"90","author":"Mitchell L","year":"2003","unstructured":"Mitchell L , AndrewM, HannaKet al. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Thromb. Haemost.90(2), 235\u2013244 (2003).","journal-title":"Thromb. Haemost."},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21222"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.tb06336.x"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.1996.tb00290.x"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.1097\/00001721-199402000-00004"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2006.06209.x"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1111\/jth.12070"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1080\/10428190410001663671"},{"key":"e_1_3_2_42_1","first-page":"CD006649","article-title":"Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer","volume":"6","author":"Akl EA","year":"2014","unstructured":"Akl EA , KahaleL, NeumannIet al. Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst. Rev.6, CD006649 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa025313"},{"key":"e_1_3_2_44_1","first-page":"CD006650","article-title":"Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer","volume":"7","author":"Akl EA","year":"2014","unstructured":"Akl EA , KahaleL, BarbaMet al. Anticoagulation for the long-term treatment of venous thromboembolism in patients with cancer. Cochrane Database Syst. Rev.7, CD006650 (2014).","journal-title":"Cochrane Database Syst. Rev."},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-09-0563"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2013.11.001"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(14)70018-3"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-0402"},{"issue":"9","key":"e_1_3_2_49_1","first-page":"782","article-title":"College of american pathologists conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy","volume":"122","author":"Olson JD","year":"1998","unstructured":"Olson JD , ArkinCF, BrandtJTet al. College of american pathologists conference XXXI on laboratory monitoring of anticoagulant therapy: laboratory monitoring of unfractionated heparin therapy. Arch. Pathol. Lab. Med.122(9), 782\u2013798 (1998).","journal-title":"Arch. Pathol. Lab. Med."},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08132.x"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.15.114","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:42:29Z","timestamp":1719124949000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.15.114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,14]]},"references-count":48,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2015,9,30]]}},"alternative-id":["10.2217\/fon.15.114"],"URL":"https:\/\/doi.org\/10.2217\/fon.15.114","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,14]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-08-14","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}